Prepare for a bad allergy season
Although, because pollen season started later this year, pollen season may be shorter than in past years, according to allergy experts.
Allergic Disorders
Can the time of day impact allergic reaction?
Symptoms and laboratory parameters of allergic disease exhibit prominent circadian variations, with symptoms worsening overnight or early in the morning.
Gas, dust, and fume exposure increases mite sensitization risk
Gas, dust, and fume exposure correlated with a doubled risk of sensitization to mites, but not other allergens.
SLIT-tablet seems safe for patients with asthma, allergic rhinitis
No serious local allergic swellings or serious allergic reactions among SLIT-tablet-treated individuals with asthma.
Secondhand smoke ups asthma, rhinitis, eczema risks through adolescence
In utero, infant exposure to tobacco smoke has been linked to increased to asthma, rhinitis risk in early childhood and eczema in later life.
FDA reviews OTC Singulair use
Inappropriate use in children under 15 years old and patients seeking relief for asthma cited as top concerns.
FDA approves Ragwitek tablet for hay fever
Ragwitek is the third sublingual immunotherapy (SLIT) the agency approved for allergies this month, after Merck’s Grastek and Greer’s OralAir.
Allergy shot during pregnancy may cut child’s risk
Association toward decreased odds of allergy among children of mother’s whose allergic rhinitis was treated with immunotherapy.
Vasomotor rhinitis and allergic conjunctivitis
The ability to differentiate between the allergic and nonallergic form of these conditions is crucial when determining treatment.
Zetonna available soon for allergic rhinitis
Zetonna is a nasal aerosol approved to treat both ocular and nasal symptoms associated with seasonal allergic rhinitis (SAR), and nasal symptoms associated with perennial allergic rhinitis (PAR) in adults and adolescents aged >12 years.
- Loading...
Loading...
Loading... 
Loading...